Product Images Vecuronium Bromide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Vecuronium Bromide NDC 51662-1547 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

SERIALIZED LABELING - 51662 1547 1 Serialized Labeling

SERIALIZED LABELING - 51662 1547 1 Serialized Labeling

BOXED WARNING - Boxed Warning

BOXED WARNING - Boxed Warning

This text is a warning about a drug and advises that it should only be administered by people who are well-trained and familiar with its actions, characteristics, and potential hazards.*

DOSAGE - DOSAGE

DOSAGE - DOSAGE

This text describes the individualization of the drug delivery rate of Vecuronium Bromide using an infusion pump with a table that provides for the amount of drug delivery rate and infusion delivery rate for different patient weights and drug concentrations. The table mentions the rate of mL/min for a solution of 0.1 ma/m (10 mg in 100 mL). It also contains a note that if the concentration of the drug is halved, the rate should be decreased by one-half.*

STRUCTURE - Structure

STRUCTURE - Structure

Not available. The text is too short and lacks context to generate a useful description.*

VIAL LABELING - Vial Label

VIAL LABELING - Vial Label

This is a warning label for Vecuronium, also known as Bromide. It is a paralyzing agent that can cause respiratory failure, and facilities must have artificial respiration immediately available. The dosage and storage instructions are found in the package insert, and it should be protected from light. There is a warning that it contains benzyl alcohol and should not be used in newborns. It can be reconstituted with bacteriostatic water or sterile water compatible with the solutions listed in the package insert, and it is for intravenous use only. The package contains 10 mg of the drug in a single-use vial, and any unused portion should be discarded within 24 hours. The drug is distributed by AuroMedics Pharma LLC from E. Windsor, NJ and is made in India.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.